WESTPAY AB
Westpay AB has signed a frame agreement with a leading European POS provider, and will be their preferred partner for payment solutions. The company provides point of sales (POS) solutions for merchants in the hospitality sector.
The initial term of the frame agreement is four years, and deliveries of payment products and services is estimated to commence in Q2 2021.
- This is exciting news for us at Westpay. This is one of the major players in Europe, and we are, of course, very proud to be teaming up with them. Now it´s all about execution and enable their business by adding our value. Again, we get the confirmation we are looking for that we are on track with a relevant offering powered by the right strategy, says Sten Karlsson, CEO at Westpay AB.
For additional information, please contact:
Sten Karlsson, CEO Westpay AB
Mobile: +46 70-555 6065
Email: sten.karlsson@westpay.se
Hans Edin, CCO Westpay AB
Mobile: +46 70-688 02 05
Email: hans.edin@westpay.se
Westpay’s Certified Adviser is Redeye AB
phone: +46 8 121 576 90, email: certifiedadviser@redeye.se
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Wolters Kluwer N.V.19.9.2025 08:00:00 CEST | Press release
Wolters Kluwer completes capital reduction
Orion Oyj19.9.2025 08:00:00 CEST | Press release
80,802 Orion Corporation A shares converted into B shares
JDE Peet's N.V.19.9.2025 07:55:00 CEST | Press release
Update on intended recommended public offer by KDP for JDE Peet's
Sampo plc19.9.2025 07:30:00 CEST | Press release
Sampo plc’s share buybacks 18 September 2025
Idorsia Pharmaceuticals Ltd19.9.2025 07:00:00 CEST | Press release
Idorsia’s JERAYGO (aprocitentan) approved in Switzerland for the treatment of resistant hypertension
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom